← Back to feed Brand & Business

Eli Lilly is handing China sales rights for a breast cancer drug to Innovent Biologics

Quartz 30 June 2026 8h ago
Eli Lilly is handing China sales rights for a breast cancer drug to Innovent Biologics
64
Relevance
9/25
Freshness
25/25
Authority
18/20
Brand Signal
10/15
Depth
2/15
Relevance Freshness Authority Brand Depth
Innovent will take over importing, marketing, and distributing Verzenios in mainland China as generic competition looms
Read Full Article → Quartz ↗